Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,020,872
+$1,753,143 QoQ
Shares Held
60,833
+795.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Neo Ivy Capital Management holds $15,852,316 across 14 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
35,826 | $4,194,149 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
10,195 | $2,495,430 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
48,937 | $2,099,886 | |
| 4 | IMNM |
Immunome Inc.
|
80,876 | $1,713,762 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
9,798 | $1,300,488 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
14,551 | $1,291,837 | |
| 7 | TECH |
BIO-TECHNE Corp
|
11,316 | $799,475 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
31,440 | $698,282 |
All Filings in TGTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,020,872 | 60,833 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $267,729 | 6,790 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $2,357,244 | 100,780 | Shares | Sole | 2024-11-18 | |
| 2023-06-30 | $375,059 | 15,099 | Shares | Sole | 2023-08-16 | |
| 2021-09-30 | $173,355 | 5,209 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $298,838 | 7,704 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $99,725 | 2,069 | Shares | Sole | 2021-10-07 | |
| 2020-12-31 | $129,373 | 2,487 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $139,366 | 5,208 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $101,471 | 5,209 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||